Silence Therapeutics plc announced retirement of Dr. Giles Campion as Chief Medical Officer and Head of Research & Development to be effective October 1, 2023, the company announced that Dr. Campion has retired from the board of directors of the Company effective July 1, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.32 USD | +1.39% | +11.43% | +33.56% |
EPS Revisions
- Stock Market
- Equities
- SLN Stock
- News Silence Therapeutics plc
- Silence Therapeutics plc Announces Retirement of Giles Campion as Chief Medical Officer, Head of Research & Development and Member of Board